-
The Relation Of Oxidative Stress Biomarkers With Proinflammatory Cytokines In Gestational Diabetes
Sema Genc, Zeynep Kusku-Kiraz, Elmire Dervisoglu, Nida Oztop, Nevin Dinccag, Figen Gurdol
Research Article: Clinical Investigation
-
The Relation Of Oxidative Stress Biomarkers With Proinflammatory Cytokines In Gestational Diabetes
Sema Genc, Zeynep Kusku-Kiraz, Elmire Dervisoglu, Nida Oztop, Nevin Dinccag, Figen Gurdol
Research Article: Clinical Investigation
-
The Relation Of Oxidative Stress Biomarkers With Proinflammatory Cytokines In Gestational Diabetes
Sema Genc, Zeynep Kusku-Kiraz, Elmire Dervisoglu, Nida Oztop, Nevin Dinccag, Figen Gurdol
Research Article: Clinical Investigation
-
The Relation Of Oxidative Stress Biomarkers With Proinflammatory Cytokines In Gestational Diabetes
Sema Genc, Zeynep Kusku-Kiraz, Elmire Dervisoglu, Nida Oztop, Nevin Dinccag, Figen Gurdol
Research Article: Clinical Investigation
-
The Relation Of Oxidative Stress Biomarkers With Proinflammatory Cytokines In Gestational Diabetes
Sema Genc, Zeynep Kusku-Kiraz, Elmire Dervisoglu, Nida Oztop, Nevin Dinccag, Figen Gurdol
Research Article: Clinical Investigation
-
The Relation Of Oxidative Stress Biomarkers With Proinflammatory Cytokines In Gestational Diabetes
Sema Genc, Zeynep Kusku-Kiraz, Elmire Dervisoglu, Nida Oztop, Nevin Dinccag, Figen Gurdol
Research Article: Clinical Investigation
-
New treatments for neurogenic detrusor overactivity
Gabriele Gaziev, Valerio Iacovelli, Luca Topazio, Daniele Bianchi & Enrico Finazzi Agro
Clinical Trail Outcomes: Clinical Investigation
-
New treatments for neurogenic detrusor overactivity
Gabriele Gaziev, Valerio Iacovelli, Luca Topazio, Daniele Bianchi & Enrico Finazzi Agro
Clinical Trail Outcomes: Clinical Investigation
-
New treatments for neurogenic detrusor overactivity
Gabriele Gaziev, Valerio Iacovelli, Luca Topazio, Daniele Bianchi & Enrico Finazzi Agro
Clinical Trail Outcomes: Clinical Investigation
-
New treatments for neurogenic detrusor overactivity
Gabriele Gaziev, Valerio Iacovelli, Luca Topazio, Daniele Bianchi & Enrico Finazzi Agro
Clinical Trail Outcomes: Clinical Investigation
-
New treatments for neurogenic detrusor overactivity
Gabriele Gaziev, Valerio Iacovelli, Luca Topazio, Daniele Bianchi & Enrico Finazzi Agro
Clinical Trail Outcomes: Clinical Investigation
-
New treatments for neurogenic detrusor overactivity
Gabriele Gaziev, Valerio Iacovelli, Luca Topazio, Daniele Bianchi & Enrico Finazzi Agro
Clinical Trail Outcomes: Clinical Investigation
-
Updating the clinical evidence on belimumab role modulating B-cell response and treatment of systemic lupus erythematosus
Ignasi Rodriguez-Pinto, Gerard Espinosa1 & Ricard Cervera
Drug Evaluation: Clinical Investigation
-
Updating the clinical evidence on belimumab role modulating B-cell response and treatment of systemic lupus erythematosus
Ignasi Rodriguez-Pinto, Gerard Espinosa1 & Ricard Cervera
Drug Evaluation: Clinical Investigation
-
Updating the clinical evidence on belimumab role modulating B-cell response and treatment of systemic lupus erythematosus
Ignasi Rodriguez-Pinto, Gerard Espinosa1 & Ricard Cervera
Drug Evaluation: Clinical Investigation
-
Updating the clinical evidence on belimumab role modulating B-cell response and treatment of systemic lupus erythematosus
Ignasi Rodriguez-Pinto, Gerard Espinosa1 & Ricard Cervera
Drug Evaluation: Clinical Investigation
-
Updating the clinical evidence on belimumab role modulating B-cell response and treatment of systemic lupus erythematosus
Ignasi Rodriguez-Pinto, Gerard Espinosa1 & Ricard Cervera
Drug Evaluation: Clinical Investigation
-
Updating the clinical evidence on belimumab role modulating B-cell response and treatment of systemic lupus erythematosus
Ignasi Rodriguez-Pinto, Gerard Espinosa1 & Ricard Cervera
Drug Evaluation: Clinical Investigation
-
Dalbavancin: re-enforcing the arsenal against Gram-positive bacteria causing skin and skin structure infections
Konstantinos Z Vardakas & Matthew E Falagas
Review: Clinical Trail Outcomes: Clinical Investigation
-
Dalbavancin: re-enforcing the arsenal against Gram-positive bacteria causing skin and skin structure infections
Konstantinos Z Vardakas & Matthew E Falagas
Review: Clinical Trail Outcomes: Clinical Investigation
-
Dalbavancin: re-enforcing the arsenal against Gram-positive bacteria causing skin and skin structure infections
Konstantinos Z Vardakas & Matthew E Falagas
Review: Clinical Trail Outcomes: Clinical Investigation
-
Dalbavancin: re-enforcing the arsenal against Gram-positive bacteria causing skin and skin structure infections
Konstantinos Z Vardakas & Matthew E Falagas
Review: Clinical Trail Outcomes: Clinical Investigation
-
Dalbavancin: re-enforcing the arsenal against Gram-positive bacteria causing skin and skin structure infections
Konstantinos Z Vardakas & Matthew E Falagas
Review: Clinical Trail Outcomes: Clinical Investigation
-
Dalbavancin: re-enforcing the arsenal against Gram-positive bacteria causing skin and skin structure infections
Konstantinos Z Vardakas & Matthew E Falagas
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of high-risk neuroblastoma in children: recent clinic trial results
Emily Greengard,Christine Hill-Kayser,Rochelle Bagatell
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of high-risk neuroblastoma in children: recent clinic trial results
Emily Greengard,Christine Hill-Kayser,Rochelle Bagatell
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of high-risk neuroblastoma in children: recent clinic trial results
Emily Greengard,Christine Hill-Kayser,Rochelle Bagatell
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of high-risk neuroblastoma in children: recent clinic trial results
Emily Greengard,Christine Hill-Kayser,Rochelle Bagatell
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of high-risk neuroblastoma in children: recent clinic trial results
Emily Greengard,Christine Hill-Kayser,Rochelle Bagatell
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of high-risk neuroblastoma in children: recent clinic trial results
Emily Greengard,Christine Hill-Kayser,Rochelle Bagatell
Review: Clinical Trail Outcomes: Clinical Investigation
-
Mesenchymal stem cells in neurological diseases
Ibrahim Kassis, Panayiota Petrou, Adi Vaknin-Dembinsky, Dimitrios Karussis
Review: Clinical Trail Outcomes: Clinical Investigation
-
Mesenchymal stem cells in neurological diseases
Ibrahim Kassis, Panayiota Petrou, Adi Vaknin-Dembinsky, Dimitrios Karussis
Review: Clinical Trail Outcomes: Clinical Investigation
-
Mesenchymal stem cells in neurological diseases
Ibrahim Kassis, Panayiota Petrou, Adi Vaknin-Dembinsky, Dimitrios Karussis
Review: Clinical Trail Outcomes: Clinical Investigation
-
Mesenchymal stem cells in neurological diseases
Ibrahim Kassis, Panayiota Petrou, Adi Vaknin-Dembinsky, Dimitrios Karussis
Review: Clinical Trail Outcomes: Clinical Investigation
-
Mesenchymal stem cells in neurological diseases
Ibrahim Kassis, Panayiota Petrou, Adi Vaknin-Dembinsky, Dimitrios Karussis
Review: Clinical Trail Outcomes: Clinical Investigation
-
Mesenchymal stem cells in neurological diseases
Ibrahim Kassis, Panayiota Petrou, Adi Vaknin-Dembinsky, Dimitrios Karussis
Review: Clinical Trail Outcomes: Clinical Investigation
-
Do clinical research networks work? The NIHR diabetes research network after six years
Eleanor Kennedy, David R Matthews
Research Update: Clinical Investigation
-
Do clinical research networks work? The NIHR diabetes research network after six years
Eleanor Kennedy, David R Matthews
Research Update: Clinical Investigation
-
Do clinical research networks work? The NIHR diabetes research network after six years
Eleanor Kennedy, David R Matthews
Research Update: Clinical Investigation
-
Do clinical research networks work? The NIHR diabetes research network after six years
Eleanor Kennedy, David R Matthews
Research Update: Clinical Investigation
-
Do clinical research networks work? The NIHR diabetes research network after six years
Eleanor Kennedy, David R Matthews
Research Update: Clinical Investigation
-
Do clinical research networks work? The NIHR diabetes research network after six years
Eleanor Kennedy, David R Matthews
Research Update: Clinical Investigation
-
Abiraterone acetate for metastatic castration-resistant prostate cancer post-docetaxel
Hein Van Poppel, Susanne Osanto,Steven Joniau
Review: Clinical Trail Outcomes: Clinical Investigation
-
Abiraterone acetate for metastatic castration-resistant prostate cancer post-docetaxel
Hein Van Poppel, Susanne Osanto,Steven Joniau
Review: Clinical Trail Outcomes: Clinical Investigation
-
Abiraterone acetate for metastatic castration-resistant prostate cancer post-docetaxel
Hein Van Poppel, Susanne Osanto,Steven Joniau
Review: Clinical Trail Outcomes: Clinical Investigation
-
Abiraterone acetate for metastatic castration-resistant prostate cancer post-docetaxel
Hein Van Poppel, Susanne Osanto,Steven Joniau
Review: Clinical Trail Outcomes: Clinical Investigation
-
Abiraterone acetate for metastatic castration-resistant prostate cancer post-docetaxel
Hein Van Poppel, Susanne Osanto,Steven Joniau
Review: Clinical Trail Outcomes: Clinical Investigation
-
Abiraterone acetate for metastatic castration-resistant prostate cancer post-docetaxel
Hein Van Poppel, Susanne Osanto,Steven Joniau
Review: Clinical Trail Outcomes: Clinical Investigation
-
Overcoming the logistics of immune monitoring of cancer patients during clinical trials
Marc S Ernstoff
Editorial: Clinical Investigation
-
Overcoming the logistics of immune monitoring of cancer patients during clinical trials
Marc S Ernstoff
Editorial: Clinical Investigation
-
Overcoming the logistics of immune monitoring of cancer patients during clinical trials
Marc S Ernstoff
Editorial: Clinical Investigation
-
Overcoming the logistics of immune monitoring of cancer patients during clinical trials
Marc S Ernstoff
Editorial: Clinical Investigation
-
Overcoming the logistics of immune monitoring of cancer patients during clinical trials
Marc S Ernstoff
Editorial: Clinical Investigation
-
Overcoming the logistics of immune monitoring of cancer patients during clinical trials
Marc S Ernstoff
Editorial: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 1, Iss 6
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 1, Iss 6
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 1, Iss 6
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 1, Iss 6
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 1, Iss 6
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 1, Iss 6
Acknowledgements: Clinical Investigation
-
An approach to personalized medicine: the BATTLE trial
Niels Reinmuth, Michael Thomas
Review Article: Clinical Investigation
-
An approach to personalized medicine: the BATTLE trial
Niels Reinmuth, Michael Thomas
Review Article: Clinical Investigation
-
An approach to personalized medicine: the BATTLE trial
Niels Reinmuth, Michael Thomas
Review Article: Clinical Investigation
-
An approach to personalized medicine: the BATTLE trial
Niels Reinmuth, Michael Thomas
Review Article: Clinical Investigation
-
An approach to personalized medicine: the BATTLE trial
Niels Reinmuth, Michael Thomas
Review Article: Clinical Investigation
-
An approach to personalized medicine: the BATTLE trial
Niels Reinmuth, Michael Thomas
Review Article: Clinical Investigation